Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Renu Virmani
Research Area(s) / Expertise:

Expertise

Heart Failure
Job title: President and Medical Director
Personal History Dr Renu Virmani was born in 1943 in Pakistan. Her father was an industrialist of Delhi and Amritsar, India.2 As the youngest girl in a family of ten children, Dr Virmani was always driven to stand out and excel. Her aunt, who was a neurologist, was instrumental in forging her ambitions to pursue medicine. “I admired her and she showed me that women can do whatever they want… View more
TR in HFpEF: Prognosis Varies by Mechanism
Added: 5 months ago Source:  Radcliffe Cardiology
A new study published in JACC has evaluated the prevalence and prognostic significance of secondary tricuspid regurgitation (STR) across the spectrum of heart failure with preserved ejection fraction (HFpEF), finding that its presence is strongly associated with pulmonary vascular disease (PVD) and that different mechanisms of STR carry distinct prognoses.¹˒²This observational study analysed data… View more

Heart Failure
Takotsubo Syndrome in a Southeast Asian Population
Author(s): Samuel Soh Heng , Ignasius Jappar , Zee Pin Ding Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Milton Packer
Research Area(s) / Expertise:

Expertise

Heart Failure
Job title: Distinguished Scholar in Cardiovascular Science
Personal History Dr Milton Packer was born to Polish immigrants in 1951 and raised in Philadelphia, US. Prior to studying medicine, he was politically active in the 1960s. In his words: “The focus of my upbringing was education, but the major guiding principle in my childhood years (and throughout my entire life) was an uncompromising sense of justice. I was always imbued with the need to… View more
José Ramón González Juanatey
Research Area(s) / Expertise:

Expertise

Heart Failure
Personal History Born in Noia and raised in Santiago de Compostela, Dr José Ramón González Juanatey is one of the most renowned cardiologists in Spain.4 Dr Juanatey is Head of the Cardiology and UCC Service of the Santiago de Compostela University Hospital Complex (CHUS) and Professor of Cardiology at the University of Santiago de Compostela (USC).3 Academic History Dr Juanatey… View more
Jack WC Tan
Research Area(s) / Expertise:

MI/ACS

Angiography

Peripheral Artery Disease - General

Intervention

 Job title: Head and Senior Consultant
Academic History Dr Jack Tan graduated from the Faculty of Medicine, the National University of Singapore in 1997. In 2007, he spent one year at UC Davis Medical Center, Sacramento with Dr John Laird to complete his peripheral vascular interventional program. He is doubly accredited for cardiology and intensive care medicine in Singapore. He is the deputy head of cardiology and director of the… View more
Dan G Halpern
Job title: MD
Personal History Dr Dan G. Halpern is a cardiologist based in the New York area. He is an Assistant Professor in the Department of Medicine at NYU Grossman School of Medicine and the Medical Director of the Adult Congenital Heart Disease Program at NYU Langone Health. “I have wanted to be a doctor since I was a child,” he says. Prior to becoming a physician, he served as a medic in the Army… View more
Danielle Belardo
Job title: Director of Preventive Cardiology & Co-Director of Research and Education
Personal History Dr Danielle Belardo is a New Yorker who relocated to Philadelphia after college to start her medical career.1 She is now a Preventive Cardiologist based in Newport Beach, California.2 In college, she started volunteering at the Alzheimer’s Association and got involved with the Leukemia & Lymphoma Society’s program to raise funds for the pediatric oncology unit at DuPont… View more
DIGIT-HF: Digitoxin Reduces Primary Outcome in Symptomatic Heart Failure with Reduced Ejection Fraction
Added: 8 months ago Source:  Radcliffe Cardiology
AUTHOR: Yazmin SadikNew findings from the DIGIT-HF trial indicate that adding low-dose digitoxin to guideline-directed medical therapy (GDMT) can reduce the risk of hospitalisation and all-cause mortality in patients with symptomatic heart failure with reduced ejection fraction (HFrEF).¹The results were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously… View more

Imaging & Diagnostics

Guidelines & Statements
GLP-1RAs: Mechanism of Action and Role in HFpEF Management
Author(s): Magdy Abdelhamid , Mostafa M Abdrabou , Emanuel Faris , et al Added: 6 months ago

Heart Failure